Revinax platform for 3D Virtual Reality Learning Techniques for Complex Medical Applications

Project Information

VR4Health

Grant agreement ID: 734989

DOI

10.3030/734989

Project closed

EC signature date 18 July 2016

Start date 1 September 2016

End date 30 November 2016

Funded under

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

REVINAX SAS
France

Periodic Reporting for period 1 - VR4Health (Revinax platform for 3D Virtual Reality Learning Techniques for Complex Medical Applications)

Reporting period: 2016-09-01 to 2016-11-30

Summary of the context and overall objectives of the project

The problem addressed by VR4Health is the inefficient surgery training currently existing. This is an issue for society given the high number of deaths per year due to medical errors, and on the other hand due to the lack of access to healthcare in remote and developing areas. The overall objective of our project is to develop a cloud-based platform integrating our mobile app, Surgevry, and training modules, which combined with the corresponding hardware (two operating room recording systems), will enable interactive virtual reality as a training method for complex medical applications. Thus, our products and services will revolutionize the way surgery is taught and conveyed, while offering a better training, with more flexibility and at an affordable cost.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

We have already recorded surgical procedures using a prototype recording system assembled from off-the-shelf parts, which has approval in France to enter the operating room. On the other hand, we have developed a first version of Obserever option and our app Surgevry is currently commercialized in versions compatible with Android and iOS operative systems. We have attended 24 events, where we carried out dissemination of our project. We have evaluated the technical, commercial and financial risks to develop VR4Health. The analysis has convinced us that we have a strong innovative project with real success potential during the commercial exploitation of a technology that will have a significant impact for both our company and customers worldwide. End-users will benefit from an affordable and portable surgical VR training thanks to the outstanding performance of our process.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

Our forecast shows that we can achieve revenues over €10 million by the fifth commercialization year (2023), and our project is expected to have a major socio-economic impact, as surgeons’ preparation will be shortened and improved before ever carrying out surgery on a patient, which will reduce deaths per year due to medical errors. Moreover, VR will reach to remote areas, thus VR4Health will improve access and quality of healthcare worldwide. End users (practicing surgeons and physicians) will be able to follow training and share content independently of the institution where they work. On the other hand, governments will be able to improve their prevention campaigns and quality of healthcare provision, while reducing training costs.

image-1.png